文献速递瓣膜外科

快速部署瓣膜与常规组织瓣膜在主动脉瓣置换术中的比较

Rapid deployment valves versus conventional tissue valves for aortic valve replacement.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-06-29

该单中心回顾性研究纳入2013至2019年2237例组织主动脉瓣置换患者,经逆概率治疗加权后每组295例。快速部署瓣膜组体外循环和交叉钳夹时间更短,但主要及次要结局无统计学显著差异,永久起搏器植入率显著更高(7%,P < .009)。结论提示快速部署瓣膜在简单主动脉瓣置换中无临床获益。

要点

  • 快速部署瓣膜缩短体外循环和交叉钳夹时间,但主要及次要结局无显著差异。
  • 快速部署瓣膜组永久起搏器植入率为7%,显著高于常规瓣膜组(P < .009)。
  • 在简单主动脉瓣置换中,快速部署瓣膜未显示临床获益。

核心结论

  • 数据提示快速部署瓣膜在简单主动脉瓣置换中无获益,需进一步研究明确适用人群。

研究设计与样本

  • 单中心回顾性 review,纳入2013至2019年所有接受组织主动脉瓣置换的患者,共2237例。
  • 患者多数为男性且年龄大于60岁,分为快速部署瓣膜组和常规缝合瓣膜组。
  • 采用逆概率治疗加权法创建基线特征相似的队列,加权后每组295例。
  • 使用Kaplan-Meier曲线和log-rank检验判断结局差异是否有统计学意义。

主要发现

  • 快速部署瓣膜组体外循环和交叉钳夹时间更短。
  • 主要结局(30天、1年、5年全因死亡率)和次要结局无统计学显著差异。
  • 快速部署瓣膜组永久起搏器植入率为7%,差异显著(P < .009)。

临床怎么用

  • 在简单主动脉瓣置换中,快速部署瓣膜虽缩短手术时间但无临床获益,选择时应权衡起搏器植入风险。

局限性

  • 本研究为单中心回顾性 review,可能存在选择偏倚。
  • 经逆概率治疗加权后每组仅295例,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Rapid deployment valves have been developed as a means to adjust for limitations in transcatheter aortic valve replacement and surgical aortic valve replacement for the management of aortic valve disease. To date, many studies have shown that although rapid deployment valves facilitate a shorter surgical aortic valve replacement, they offer no clinical benefit. The purpose of this study was to compare the outcomes of rapid deployment valves with conventional surgical aortic valve replacement. METHODS: This study was a retrospective review of all patients undergoing tissue aortic valve replacement at a single center. The majority of patients were men and aged more than 60 years. Patients were categorized into 2 groups: (1) rapid deployment valves and (2) conventional sutured valve. Inverse probability treatment weighting method was used to create a cohort of patients with similar baseline characteristics. Kaplan-Meier curves and log-rank tests were used to determine if there were statistically significant differences in outcomes. Primary outcome was all-cause mortality at 30 days, 1 year, and 5 years. RESULTS: A total of 2237 patients made up the study population from 2013 to 2019. After inverse probability treatment weighting, there were 295 patients in each group. Shorter cardiopulmonary bypass and crossclamp times were found with the rapid deployment valves. No statistically significant difference was found in the primary and secondary outcomes. There was a significant difference in the rate of permanent pacemaker insertion with a 7% pacemaker rate in the rapid deployment valve group (P < .009). CONCLUSIONS: The data suggest that rapid deployment valves offer no benefit in straightforward aortic valve replacement, and further study will help identify which patient population the valve is suited for.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. White A, Bozso SJ, Lakey O, et al. Rapid deployment valves versus conventional tissue valves for aortic valve replacement. J Thorac Cardiovasc Surg. 2020. PMID: 32747118. doi:10.1016/j.jtcvs.2020.06.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。